Evidence map›Paper›PMID 39731171›Full record

ReviewJournal of translational medicine2024

Sex differences in disease: sex chromosome and immunity.

Zuxi Feng, Minjing Liao, Liansheng Zhang

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Decoding Burkholderia Cepacia complex: recA-based species differentiation and antimicrobial susceptibility pattern.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zuxi Feng *The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, 730000, China.ORCID 0000-0002-9846-4027
Minjing Liao *The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, 730000, China.
Liansheng ZhangThe Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, 730000, China. doctorzhanglsh@sina.com.

Funding

Cuiying Scientific Training Program for Undergraduates of The Second Hospital & Clinical Medical School, Lanzhou University CYXZ2024-02Lanzhou University Student Innovation and Entrepreneurship Action Plan Funding Project 20240050032National Natural Science Foundation of China 82360029
6 · The paper itself

Abstract

Sex is a fundamental biological variable that influences immune system function, with sex chromosomes (X and Y) playing a central role in these differences. Despite substantial evidence of disparities in immune responses between males and females, biomedical research has historically overlooked sex as a critical factor. This oversight has contributed to the observed disparities in susceptibility to autoimmune diseases, infectious diseases, and malignancies between the sexes. In this review, we address the phenomena and mechanisms through which aberrant expression of sex chromosome-linked genes contributes to sex-based differences in immune responses. We specifically focus on the implications of X chromosome inactivation (XCI) escape and loss of Y chromosome (LOY). Our review aims to elucidate the molecular mechanisms driving these sex-based differences, with particular emphasis on the interactions between sex chromosome genes and immune cells in both males and females. Additionally, we discuss the potential impact of these differences on disease susceptibility and identify prospective therapeutic targets. As personalized and precision medicine advances, it is crucial to integrate sex differences into immunological research and clinical trials. We advocate for an increased focus on sex-based considerations in fundamental, translational, and clinical research to promote personalized, sex-specific healthcare.

Indexed as

ImmunitySex CharacteristicsAnimalsChromosomes, Human, YDiseaseFemaleHumansMaleSex ChromosomesX Chromosome InactivationImmunityLoss of Y chromosomeSex chromosomeSex differencesX chromosome inactivation

Identifiers

PMID39731171
PMCPMC11673612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.